Rainbow Rare Earths sees competitive advantage in new separation technology for Phalaborwa project. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

IN BRIEF: Apollon Formularies takes steps to raise output capacity

Wed, 15th Sep 2021 19:25

Apollon Formularies PLC - London-based medical cannabis pharmaceutical firm - Expands production facility in Negril, Jamaica through the purchase of a new distiller, which will lead to the generation of additional revenue.

There is also the installation of a sonicator allowing for the production of nanoparticle medicines and water-oil emulsions, and the acquisition of an industrial freeze drier, allowing for more flexibility to store freeze dried biomass.

"We are delighted to have expanded our state-of-the-art production facility in Negril. Our new extraction facility significantly increases our production capabilities whilst also deepening our future product offering and improving product storage. Upgrading our facility means that we have more than enough production capability to operationally support Apollon's activities as we continue our strategy to expand our local and, eventually, global footprint," says Chief Operating Officer Stephen Barnhill Jr.

Current stock price: 2.7 pence

Year-to-date change: down 58%

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.